Following a number of recent transactions in the space, PMSI share insights on the RWD/RWE landscape.
Our key insights:
- In the last few years, Digital Health solutions have seen rapid adoption driven in part by greater value placed on healthcare post-COVID – as governments and corporations aim to generate more value from the data inherent within healthcare systems worldwide
- Real World Data (RWD) and Evidence (RWE) solutions in particular have seen strong interest due to growing regulatory support and patient data availability, as well as a shift towards performance-based contracts alongside Pharma investment into advanced data analytics
- As a result, what has traditionally been a space for venture capital is increasingly attracting private equity and other later-stage investors as they seek to own datasets underlying the shift towards a more digital healthcare system
Read the full article below:
Article
PMSI supports TTC Group's acquisition of Miad H...
Trusted training and compliance expert, TTC Group, continues its strategic expansion in critical training and compliance services with the acquisition of non...